BioPharma FTC sues major pharmacy benefit managers over insulin prices By - 0 11 FacebookTwitterPinterestWhatsApp The agency brought action against Caremark, Express Scripts and Optum Rx on Friday, and warned that all drug manufacturers “should be on notice” as well.